Matthew Scalo

Matthew Scalo

Investor Relations Contact bij MYRIAD GENETICS, INC.
Finance
Health Technology
Consumer Services

Profiel

Matthew Scalo is Senior Vice President-Investor Relations at Myriad Genetics, Inc. since 2022.
Former roles include Senior Director-Investor Relations at Luminex Corp., Investor Relations Contact at NextGen Healthcare, Inc., Senior Research Analyst at Allspring Global Investments LLC, Research Analyst at Canaccord Adams, Inc. from 2004 to 2010, VP, Investor Relations & Corporate Development at Cutera, Inc., Associate at Broadpoint.
Gleacher Securities in 2003, and Research Analyst at Canaccord Genuity, Inc. in 2010.
Education includes an MBA from the University of Notre Dame and an undergraduate degree from the University of California, Davis.

Actieve functies van Matthew Scalo

BedrijvenFunctieBegin
MYRIAD GENETICS, INC. Investor Relations Contact 01-08-2022

Eerdere bekende functies van Matthew Scalo

BedrijvenFunctieEinde
Analyst-Equity 31-12-2010
Analyst-Equity 22-04-2010
Analyst-Equity 31-12-2003
Analyst-Equity 31-12-2002
NEXTGEN HEALTHCARE, INC. Investor Relations Contact -
Ervaring van Matthew Scalo in detail bekijken

Opleiding van Matthew Scalo

Ervaring
Beklede functies

Actief

Inactief

Beursgenoteerde bedrijven

Bedrijven in privébezit

Connecties

76

Eerstegraads connecties

10

Bedrijven verbonden in de eerste graad

Man

Vrouw

Besturend

Uitvoerend

Verwante bedrijven

Bedrijven in privébezit10

Technology Services

Health Technology

Finance

Health Technology

Finance

Health Technology

Consumer Services

Finance

Consumer Services

Finance

  1. Beurs
  2. Insiders
  3. Matthew Scalo